JOURNAL OF SURGICAL ONCOLOGY, cilt.95, sa.6, ss.507-512, 2007 (SCI-Expanded)
Background: In this non-randomized study we aimed to assess the efficacy of the addition of low molecular weight heparin (LMWH) to gemcitabine (GEM) plus cisplatinum (CDDP) combination chemotherapy on survival by prevention of thromboembolic complications in patients with advanced pancreatic cancer (APC).